As data on the clinical characteristics of pseudohypoaldosteronism type 1 (PHA1) among Indian patients remain scarce, a study evaluated the clinical, biochemical, and molecular characteristics, along with treatment outcomes, in nine children with PHA1 across six tertiary care centers in South India. This multicenter retrospective study analyzed data collected between 2022 and 2025. All nine children had the systemic form of PHA1 (PHA1B), with a median age of 14 days at presentation. Parental consanguinity was observed in seven patients.
All presented with hyponatremia (median serum sodium, 124 mEq/L) and hyperkalemia (median serum potassium, 8.0 mEq/L). Eight novel homozygous variants were identified in SCNN1A (n = 2), SCNN1B (n = 3), and SCNN1G (n = 3). Three patients remained stable with oral sodium supplementation, while six died, mainly due to sepsis (n = 2) or treatment…